Net Income Per Share

9 Months Ended

Oct. 29, 2022

NOTE 13—NET INCOME PER SHARE

The calculation of our net income per share is as follows:


	THREE MONTHS ENDED				NINE MONTHS ENDED
	OCTOBER 29,			OCTOBER 30,	OCTOBER 29,		OCTOBER 30,
	2022			2021	2022		2021

		(in thousands, except share and per share amounts)
Net income	$	98,760	$	184,099	$	421,746	$	541,501
Loss on extinguishment of debt		—				169,578
Net income available to common stockholders⁽¹⁾	$	98,760			$	591,324

Weighted-average shares—basic		23,681,482		21,430,557		23,588,464		21,200,146
Effect of dilutive stock-based awards		2,209,736		6,462,775		2,943,274		6,645,663
Effect of dilutive convertible senior notes⁽²⁾		207,047		3,397,747		724,173		3,647,587
Weighted-average shares—diluted		26,098,265		31,291,079		27,255,911		31,493,396
Basic net income per share	$	4.17	$	8.59	$	25.07	$	25.54
Diluted net income per share	$	3.78	$	5.88	$	21.70	$	17.19

(1)	Effective the first quarter of fiscal 2022 upon adoption of ASU 2020-06, the loss on extinguishment of debt related to convertible securities is added back to net income to calculate net income per share.

(2)

We adopted ASU 2020-06 in the first quarter of fiscal 2022, and the adoption requires the dilutive impact of the 2023 Notes and 2024 Notes for diluted net income per share purposes to be determined under the if-converted method which assumes share settlement of the entire convertible debt instrument. Prior to adoption of ASU 2020-06, we applied the treasury stock method to determine the dilutive impact of the 2023 Notes and 2024 Notes for diluted net income per share purposes.

The 2023 Notes and the 2024 Notes have an impact on our dilutive share count beginning at stock prices of $193.65 per share and $211.40 per share, respectively. The warrants associated with the 2023 Notes and 2024 Notes had an impact on our dilutive share count beginning at stock prices of $309.84 per share and $338.24 per share, respectively. The warrants associated with the 2023 Notes and 2024 Notes were repurchased in April 2022 and, as a result, no warrant instruments are outstanding as of October 29, 2022. Accordingly, the warrants have no impact on our dilutive shares post-repurchase. Refer to Note 9—Convertible Senior Notes.

The following number of options and restricted stock units were excluded from the calculation of diluted net income per share because their inclusion would have been anti-dilutive:


	THREE MONTHS ENDED		NINE MONTHS ENDED
	OCTOBER 29,	OCTOBER 30,	OCTOBER 29,	OCTOBER 30,
	2022	2021	2022	2021
Options	1,084,920	121,587	1,083,745	86,474
Restricted stock units	19,310	—	19,443	—
Total anti-dilutive stock-based awards	1,104,230	121,587	1,103,188	86,474